These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 17286522

  • 1. The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial.
    Nasrallah HA.
    J Clin Psychiatry; 2007; 68 Suppl 1():5-11. PubMed ID: 17286522
    [Abstract] [Full Text] [Related]

  • 2. The CATIE schizophrenia trial: results, impact, controversy.
    Manschreck TC, Boshes RA.
    Harv Rev Psychiatry; 2007; 15(5):245-58. PubMed ID: 17924259
    [Abstract] [Full Text] [Related]

  • 3. What do large scale studies of medication in schizophrenia add to our management strategies?
    Agius M, Davis A, Gilhooley M, Chapman S, Zaman R.
    Psychiatr Danub; 2010 Jun; 22(2):323-8. PubMed ID: 20562774
    [Abstract] [Full Text] [Related]

  • 4. Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians?
    Citrome L, Stroup TS.
    Int J Clin Pract; 2006 Aug; 60(8):933-40. PubMed ID: 16893436
    [Abstract] [Full Text] [Related]

  • 5. Discontinuing and switching antipsychotic medications: understanding the CATIE schizophrenia trial.
    Weiden PJ.
    J Clin Psychiatry; 2007 Aug; 68 Suppl 1():12-9. PubMed ID: 17286523
    [Abstract] [Full Text] [Related]

  • 6. Selection of atypical antipsychotics for the management of schizophrenia.
    Sprague DA, Loewen PS, Raymond CB.
    Ann Pharmacother; 2004 Feb; 38(2):313-9. PubMed ID: 14742771
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T, Weinbrenner S, Busse R, Juckel G, Gericke CA.
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Selection of antipsychotic drugs in a psychiatric hospital based on the results of CATIE study].
    Gutiérrez-Suela F.
    Farm Hosp; 2008 Jun; 32(2):83-90. PubMed ID: 18783707
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antipsychotic safety and efficacy concerns.
    Meyer JM.
    J Clin Psychiatry; 2007 Jun; 68 Suppl 14():20-6. PubMed ID: 18284274
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of antipsychotics for outpatients with chronic schizophrenia.
    Obradovic M, Mrhar A, Kos M.
    Int J Clin Pract; 2007 Dec; 61(12):1979-88. PubMed ID: 17997804
    [Abstract] [Full Text] [Related]

  • 16. Heterogeneity of treatment effects in schizophrenia.
    Stroup TS.
    Am J Med; 2007 Apr; 120(4 Suppl 1):S26-31. PubMed ID: 17403379
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The CATIE and CUtLASS studies in schizophrenia: results and implications for clinicians.
    Naber D, Lambert M.
    CNS Drugs; 2009 Aug; 23(8):649-59. PubMed ID: 19594194
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quality of life in the long-term treatment and the role of second-generation antipsychotics.
    Mohr P.
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():117-33. PubMed ID: 17262004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.